A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAPHIM, Carlos Eduardo. Investigação dos aspectos metabólicos da puberdade precoce central. 2024. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2024. Disponível em: https://www.teses.usp.br/teses/disponiveis/5/5135/tde-19062024-165829/. Acesso em: 19 out. 2024.
APA
Seraphim, C. E. (2024). Investigação dos aspectos metabólicos da puberdade precoce central (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/5/5135/tde-19062024-165829/
NLM
Seraphim CE. Investigação dos aspectos metabólicos da puberdade precoce central [Internet]. 2024 ;[citado 2024 out. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/5/5135/tde-19062024-165829/
Vancouver
Seraphim CE. Investigação dos aspectos metabólicos da puberdade precoce central [Internet]. 2024 ;[citado 2024 out. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/5/5135/tde-19062024-165829/
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, v. 12, n. 2, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12020144. Acesso em: 19 out. 2024.
APA
Machado, R. R. G., Candido, E. D. de O., Aguiar, A. S., Chalup, V. N., Sanches, P. R., Dorlass, E. G., et al. (2024). Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, 12( 2). doi:10.3390/vaccines12020144
NLM
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/vaccines12020144
Vancouver
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/vaccines12020144
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Leonardo et al. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience. Clinical Immunology, v. 262, p. 51-52, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2024.110132. Acesso em: 19 out. 2024.
APA
Mendonça, L., Pontillo, A., Freschi-Barros, S., Melato, A., Cunha, A. L., Ianhez, M., et al. (2024). What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience. Clinical Immunology, 262, 51-52. doi:https://doi.org/10.1016/j.clim.2024.110132
NLM
Mendonça L, Pontillo A, Freschi-Barros S, Melato A, Cunha AL, Ianhez M, Osaku F, Carvalho LM de, Didier F, Cavalcanti A, Carlos LR, Takano O, Robazzi T, Alcantara C, Francescantonio I, Frèmond M-L, Kalil Filho JE. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience [Internet]. Clinical Immunology. 2024 ; 262 51-52.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.clim.2024.110132
Vancouver
Mendonça L, Pontillo A, Freschi-Barros S, Melato A, Cunha AL, Ianhez M, Osaku F, Carvalho LM de, Didier F, Cavalcanti A, Carlos LR, Takano O, Robazzi T, Alcantara C, Francescantonio I, Frèmond M-L, Kalil Filho JE. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience [Internet]. Clinical Immunology. 2024 ; 262 51-52.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.clim.2024.110132
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARDUCCI, Natalia Sudan et al. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells. BLOOD CELLS MOLECULES AND DISEASES, v. 104, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58756. Acesso em: 19 out. 2024.
APA
Parducci, N. S., Garnique, A. D. M. B., Lima, K. C. de, Carlos, J. A. E. G., Fonseca, N. P., Miranda, L. B. L. D., et al. (2024). Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells. BLOOD CELLS MOLECULES AND DISEASES, 104. doi:10.1016/j.bcmd.2023.102799
NLM
Parducci NS, Garnique ADMB, Lima KC de, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells [Internet]. BLOOD CELLS MOLECULES AND DISEASES. 2024 ; 104[citado 2024 out. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
Vancouver
Parducci NS, Garnique ADMB, Lima KC de, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells [Internet]. BLOOD CELLS MOLECULES AND DISEASES. 2024 ; 104[citado 2024 out. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Emilia M et al. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. Human genetics and genomics advances, v. 5, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57446. Acesso em: 19 out. 2024.
APA
Pinto, E. M., Rave, C. F., Figueiredo, B. C., Salvador, H., Teixeira, M. R., Pinto, C., et al. (2024). Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. Human genetics and genomics advances, 5( 1). doi:10.1016/j.xhgg.2023.100244
NLM
Pinto EM, Rave CF, Figueiredo BC, Salvador H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility [Internet]. Human genetics and genomics advances. 2024 ; 5( 1):[citado 2024 out. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57446
Vancouver
Pinto EM, Rave CF, Figueiredo BC, Salvador H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility [Internet]. Human genetics and genomics advances. 2024 ; 5( 1):[citado 2024 out. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57446
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Leonardo Oliveira et al. Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation. Clinical and Experimental Immunology, p. 21 , 2024Tradução . . Disponível em: https://doi.org/10.1093/cei/uxae069. Acesso em: 19 out. 2024.
APA
Mendonça, L. O., Leal, V. N. C., Roa, M. E. G. V., Barros, S. F. de, Kalil Filho, J. E., & Pontillo, A. (2024). Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation. Clinical and Experimental Immunology, 21 . doi:10.1093/cei/uxae069
NLM
Mendonça LO, Leal VNC, Roa MEGV, Barros SF de, Kalil Filho JE, Pontillo A. Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation [Internet]. Clinical and Experimental Immunology. 2024 ;21 .[citado 2024 out. 19 ] Available from: https://doi.org/10.1093/cei/uxae069
Vancouver
Mendonça LO, Leal VNC, Roa MEGV, Barros SF de, Kalil Filho JE, Pontillo A. Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation [Internet]. Clinical and Experimental Immunology. 2024 ;21 .[citado 2024 out. 19 ] Available from: https://doi.org/10.1093/cei/uxae069